Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117024) titled 'Clinical Study on Three-Dimensionally Large-Scale Prepared Umbilical Cord Mesenchymal Stem Cell Exosomes for the Treatment of Moderate-to-Severe Dry Eye Disease and Its Mechanism in Mediating Ocular Surface Immune-Inflammatory Regulation' on Jan. 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shenzhen Nanshan People's Hospital
Condition:
Dry eye syndrome
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: MSC Exosome Treatment Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/show...